Invesco Health Care Invstor holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Invesco Health Care Fund Investor Class GTHIX
- NAV / 1-Day Return 37.79 / +1.45 %
- Total Assets 1.2B
-
Adj. Expense Ratio
1.070%
- Expense Ratio 1.060%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 59%
USD | NAV as of Jun 12, 2026 | 1-Day Return as of Jun 12, 2026, 12:11 AM GMT+0
Morningstar’s Analysis GTHIX
Will GTHIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the GTHIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of GTHIX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 43.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 9.65 | 109M | Healthcare |
Johnson & Johnson | 5.85 | 66M | Healthcare |
AstraZeneca PLC | 4.18 | 47M | Healthcare |
Gilead Sciences Inc | 3.90 | 44M | Healthcare |
UnitedHealth Group Inc | 3.79 | 43M | Healthcare |
argenx SE ADR | 3.66 | 41M | Healthcare |
AbbVie Inc | 3.62 | 41M | Healthcare |
McKesson Corp | 3.43 | 39M | Healthcare |
Cencora Inc | 3.12 | 35M | Healthcare |
Welltower Inc | 2.31 | 26M | Real Estate |
United States